Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Paclitaxel
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
First Patient Enrolled in DUBSTENT DIABETES Trial to Improve PCI Outcomes in Diabetics
Details : A combination of the Pantera™ Lux™ DCB Catheter (Paclitaxel-coated balloons), is being investigated for the treatment of diabetes mellitus.
Product Name : Pantera Lux DCB
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
September 11, 2025
Lead Product(s) : Paclitaxel
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
